Grant: ARIA TA3: Transforming Clinical Trial Design Using Safe AI (Advanced Research and Invention Agency (ARIA) → University of Oxford)
The record claims the grantee is 'University of Oxford,' but the source clearly identifies Lindus Health as the primary grant recipient ('ARIA has granted funds to anti-clinical research organisation (CRO) Lindus Health'). While University of Oxford is mentioned as a collaborating partner through Nobuko Yoshida's research group, it is not the grantee. The project name is also slightly different in the source ('Transforming clinical trial design using safe and reliable AI' vs. the record's 'ARIA TA3: Transforming Clinical Trial Design Using Safe AI'), though this is a minor variation. The critical contradiction is the grantee entity.
Our claim
entire recordNo record data available.
Source evidence
1 src · 1 checkNoteThe record claims the grantee is 'University of Oxford,' but the source clearly identifies Lindus Health as the primary grant recipient ('ARIA has granted funds to anti-clinical research organisation (CRO) Lindus Health'). While University of Oxford is mentioned as a collaborating partner through Nobuko Yoshida's research group, it is not the grantee. The project name is also slightly different in the source ('Transforming clinical trial design using safe and reliable AI' vs. the record's 'ARIA TA3: Transforming Clinical Trial Design Using Safe AI'), though this is a minor variation. The critical contradiction is the grantee entity.